Last reviewed · How we verify
WP1122
At a glance
| Generic name | WP1122 |
|---|---|
| Sponsor | Moleculin Biotech, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study to Assess the Safety and Pharmacokinetics of WP1122 in Healthy Volunteers (PHASE1)
- Clinical Trial of Efficacy and Safety of Oral Drug in Adult Patients With COVID-19 (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- WP1122 CI brief — competitive landscape report
- WP1122 updates RSS · CI watch RSS
- Moleculin Biotech, Inc. portfolio CI